BRIEF published on 09/23/2026 at 08:25, 1 month 16 days ago ViferaXS Secures €12 Million for Cancer Trial and Pipeline Expansion Clinical Trials Oncology Pipeline Cancer Immunotherapy Biotechnology Investment ViferaXS Funding
BRIEF published on 09/23/2026 at 08:25, 1 month 16 days ago ViferaXS lève 12 millions d'euros pour un essai clinique sur le cancer et l'expansion de son portefeuille de produits. Essais Cliniques Pipeline En Oncologie Investissement En Biotechnologie Immunothérapie Du Cancer Financement ViferaXS
PRESS RELEASE published on 09/23/2026 at 08:20, 1 month 16 days ago ViferaXS Raises €12 Million to Advance Phase II Trial in Chronic Lymphocytic Leukemia and Expand Its Oncology Pipeline ViferaXS raises €12 million for Phase II trial in Chronic Lymphocytic Leukemia, advancing peptide-based cancer immunotherapy. SPRIND and Huma lead funding round Phase II Trial Cancer Immunotherapy €12 Million ViferaXS Chronic Lymphocytic Leukemia
Published on 11/06/2026 at 22:15, 2 days 10 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 20 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 20 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 20 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 08:15, 50 minutes ago EQS-Adhoc: Airbus SE: Airbus commences multi-year share buyback programme, with launch of the first tranche
Published on 11/09/2026 at 08:05, 1 hour ago Onodrim Industries secures $300 million Series A at $1.3 billion valuation to strengthen Europe's defence and industrial foundations
Published on 11/09/2026 at 08:00, 1 hour 5 minutes ago Aquis Stock Exchange: Transfer to Apex segment
Published on 11/09/2026 at 07:00, 2 hours 5 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 2 hours 5 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 2 hours 5 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 2 hours 5 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 13 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
